Champions Oncology (CSBR) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.07 -0.2%
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q2 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $11.57 million versus the consensus estimate of $12.82 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
